"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Gland Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations	Chairman : SRINIVAS SADU
Home : MNC Associate	Book Value: 655.111941
BSE Code : 543245	Market Cap: 48874.56
NSE Code : GLAND	P / E : 34.6

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Type	1Qtr	4Qtr	3Qtr	2Qtr
Net Sales	1286.64	1261.59	1177.51	1074.15
Other Income	58.82	106.36	60.21	82.59
Total Income	1345.46	1367.95	1237.72	1156.74
Total Expenditure	813.13	753.88	780.23	699.27
Operating Profit	532.33	614.07	457.49	457.48
Interest	0.69	6.17	0.50	3.97
Gross Profit	531.64	607.91	456.99	453.51
Depreciation	43.95	43.11	44.53	44.84
Tax	125.19	143.21	110.21	105.90
Deferred Tax	-1.89	1.13	-5.60	0.78
Reported Profit After Tax	364.39	420.45	307.85	302.00

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527